Coverage
-
November 24, 2015
A New Jersey federal judge signed off Tuesday on a permanent injunction barring Par Pharmaceutical Inc. from selling a generic version of Shire LLC's attention deficit hyperactivity disorder medication Adderall XR.
2 other articles on this case.
View all »